Krystal Biotech

About:

Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..

Top Investors: Frazier Life Sciences, Frazier Healthcare Partners, Redmile Group, Braidwell, Avoro Capital Advisors

Description:

Krystal Biotech is a biopharmaceutical company using gene therapy to develop best in class treatments that provide significant clinical benefit for patients suffering from rare debilitating disorders.

Total Funding Amount:

$546M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Pittsburgh, Pennsylvania, United States

Founded Date:

2015-01-01

Contact Email:

inquiries(AT)krystalbio.com

Founders:

Suma Krishnan

Number of Employees:

101-250

Last Funding Date:

2023-05-21

IPO Status:

Public

Industries:

Biopharma

Biotechnology

Health Care